According to Chemed's latest financial reports the company's current revenue (TTM) is $2.16 B. In 2022 the company made a revenue of $2.13 B a decrease over the years 2021 revenue that were of $2.13 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $2.16 B | 1.39% |
2022 | $2.13 B | -0.2% |
2021 | $2.13 B | 2.87% |
2020 | $2.07 B | 7.27% |
2019 | $1.93 B | 8.75% |
2018 | $1.78 B | 6.96% |
2017 | $1.66 B | 5.7% |
2016 | $1.57 B | 2.17% |
2015 | $1.54 B | 5.98% |
2014 | $1.45 B | 3.04% |
2013 | $1.41 B | -1.17% |
2012 | $1.43 B | 5.46% |
2011 | $1.35 B | 5.89% |
2010 | $1.28 B | 7.59% |
2009 | $1.19 B | 3.59% |
2008 | $1.14 B | 4.44% |
2007 | $1.10 B | 8% |
2006 | $1.01 B | 9.94% |
2005 | $0.92 B | 25.99% |
2004 | $0.73 B | 138.07% |
2003 | $0.30 B | -20.36% |
2002 | $0.38 B | -19.06% |
2001 | $0.47 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() LHC Group LHCG | $2.28 B | 5.46% | ๐บ๐ธ USA |
![]() Amedisys AMED | $2.23 B | 3.22% | ๐บ๐ธ USA |
![]() Balchem BCPC | $0.94 B | -56.29% | ๐บ๐ธ USA |
![]() Sensient Technologies
SXT | $1.45 B | -32.99% | ๐บ๐ธ USA |